The Nursing and Midwifery Council (NMC) has announced important updates to its position on remote prescribing from 1 June 2025.
This regulation affects those prescribing non-surgical cosmetic treatments, such as, anti-wrinkle injections.
The NMC has conducted research and found there is:
- “Public support for strengthened prescribing practices to improve safety
- A lack of awareness among patients about the prescription status of medicines used in non-surgical cosmetic treatments
- Concerns about treatments occurring in unregulated environments without adequate oversight”
The NMC now requires its members to carry out “face-to-face consultations to address the above concerns by allowing prescribers to conduct comprehensive assessments of each patient and minimise potential risks associated with cosmetic medicines.”
The NMC states:
“If you are a nurse or midwife prescriber in the aesthetics sector, you will now need to:
- Carry out in-person consultations before prescribing non-surgical cosmetic medicines
- Thoroughly document consultations and the informed consent process
- Adapt your practice to comply with the updated NMC standards effective from 1 June 2025
Clinic owners and operators employing nurse or midwife prescribers should review current protocols and adjust operational practices accordingly to meet these new regulatory requirements.”
For more information, please go to: NMC updates rules on cosmetic prescribing 2025
If you wish to discuss how the above impacts your insurance, please contact cathedral@rsrisk.solutions or telephone us on 01342 580106 and ask for the Aesthetics, Health and Wellness Team.
